Results 1 to 10 of about 5,085,125 (242)
Late-onset Graves’ disease after hemithyroidectomy: a case report [PDF]
Journal of Medical Case ReportsBackground Among hyperthyroidism cases, Graves’ disease is the most common, with incidence peaking between 30 and 60 years of age. Hemithyroidectomy is sometimes performed for conditions such as thyroid tumors, and Graves’ disease may develop from the ...
Sayaka Mabuchi +4 more
doaj +2 more sources
Graves’ disease: review of disease characteristics, burden, and treatments [PDF]
Frontiers in EndocrinologyGraves’ disease, the most common cause of hyperthyroidism, is a chronic autoimmune disorder that can lead to serious health problems. Treatment options for Graves’ hyperthyroidism have not changed in several decades and include antithyroid drugs (ATDs ...
Lesley-Ann Miller-Wilson +5 more
doaj +2 more sources
Journal of Education, Health and Sport, 2023 Background: Graves' disease is responsible for 60-80% causes of hyperthyreosis. An important role in the pathogenesis is played by anti-TSHR immunoglobulins (TRAb), that stimulate TSH receptors leading to excessive hormone synthesis and release by the ...
Natalia Woś +9 more
doaj +1 more source
Graves' Disease Affecting one Thyroid lobe (Unilateral Graves' Disease): Case Report [PDF]
Egyptian Journal of Nuclear Medicine, 2010 We report a 63-year-old male who was referred to nuclear medicine unit for thyroid scanning with provisional diagnosis of Graves' disease. The patient presented to endocrinology clinic few days before referral with clinical features of heart failure and ...
Sherin Wagih
doaj +1 more source
Graves-Basedow disease and potential risk factors [PDF]
Vojnosanitetski Pregled, 2008 Background/Aim. Graves-Basedow disease is a common multifactorial genetic syndrome, which is determined by several genes and environmental factors. The aim of the present study was to investigate the presence of risk factors for developing Graves-Basedow
Živanović Dušica +3 more
doaj +1 more source
The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy, 2022 Graves' disease is an autoimmune thyroid disease with several characteristic symptoms and signs. Graves' ophthalmopathy, an inflammatory disease in the orbital area, is the main extrathyroid manifestation of Graves' disease.
Herry Krisnata Ginting, Soebagijo Adi
doaj +1 more source
Archives of Endocrinology and Metabolism, 2020 Objective Graves’ disease (GD) is the main cause of hyperthyroidism among adults. It is an autoimmune condition classically marked by the Merserburg Triad (goiter, thyrotoxicosis, and orbitopathy), but the change in presentation of GD over time has ...
Wanesa Pinto +4 more
doaj +1 more source
Rituximab in the treatment of Graves’ orbitopathy: latest updates and perspectives
Endocrine Connections, 2022 Graves’ orbitopathy (GO) is a potentially sight-threatening and disfiguring, extrathyroidal manifestation of Graves’ disease. It often impairs patients’ qu ality of life, causing severe social and psychological sequelae.
Jakub Supronik +3 more
doaj +1 more source
Radioiodine treatment for graves’ disease: a 10-year Australian cohort study
BMC Endocrine Disorders, 2018 Background Radioactive iodine (I131) is a common definitive treatment for Graves’ Disease. Potential complications include worsening, or new development of Graves’ eye disease and development of a radiation thyroiditis.
Erin Fanning +2 more
doaj +1 more source
A case report of immune thrombocytopenic purpura as a rare Harbinger of Graves’ disease
Journal of Clinical and Translational Endocrinology Case Reports, 2022 Graves’ disease is one of the most common forms of autoimmune hyperthyroidism and has been linked with multiple or family histories of autoimmune diseases. In most cases, Graves' disease diagnosis is easily made by recognizing goiter, ophthalmopathy, and
Handoko Hariyono, Jongky Hendro Prajitno
doaj +1 more source